Drug class · Oncology & immunology
Monoclonal antibodies Drug Codes & NDCs
Products the FDA listing tags with the monoclonal-antibody chemical structure class, plus the PD-1, PD-L1 and CD20 antibody classes. Not every antibody product carries these tags, so treat this list as a starting point rather than a complete census.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Truximarituximab-abbs | Rituximab 10 mg/mL | Injection, SolutionIntravenous | Cephalon, Inc. | 63459-104 |
| Unloxcytcosibelimab | Cosibelimab 300 mg/5mL | Injection, SolutionIntravenous | Sun Pharmaceutical Industries, Inc. | 70095-130 |
| Vectibixpanitumumab | Panitumumab 100 mg/5mL | SolutionIntravenous | Amgen, Inc | 55513-954 |
| Vectibixpanitumumab | Panitumumab 400 mg/20mL | SolutionIntravenous | Amgen, Inc | 55513-956 |
| Yusimryadalimumab-aqvh | Adalimumab 40 mg/.8mL | Injection, SolutionSubcutaneous | Coherus BioSciences Inc | 70114-210 |
| Yusimryadalimumab-aqvh | Adalimumab 40 mg/.8mL | Injection, SolutionSubcutaneous | Coherus BioSciences Inc | 70114-220 |
| Yusimryadalimumab-aqvh | Adalimumab 40 mg/.8mL | Injection, SolutionSubcutaneous | Meitheal Pharmaceuticals Inc. | 71288-815 |
| Yusimryadalimumab-aqvh | Adalimumab 40 mg/.8mL | Injection, SolutionSubcutaneous | Meitheal Pharmaceuticals Inc. | 71288-816 |
| Yusimryadalimumab-aqvh | Adalimumab 40 mg/.4mL | Injection, SolutionSubcutaneous | Meitheal Pharmaceuticals Inc. | 71288-817 |
| Yusimryadalimumab-aqvh | Adalimumab 80 mg/.8mL | Injection, SolutionSubcutaneous | Meitheal Pharmaceuticals Inc. | 71288-818 |
| Zynyzretifanlimab-dlwr | Retifanlimab 25 mg/mL | InjectionIntravenous | Incyte Corporation | 50881-006 |